HBV Genotype: A Significant Risk Factor in Determining Which Patients With Chronic HBV Infection Should Undergo Surveillance for HCC: The Hepatitis B Alaska Study-Reference-Cited by-同舟云学术

HBV Genotype: A Significant Risk Factor in Determining Which Patients With Chronic HBV Infection Should Undergo Surveillance for HCC: The Hepatitis B Alaska Study

Published:2021-09-20 Issue:6 Volume:74 Page:2965-2973
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

McMahon Brian J.¹²³,Nolen Leisha D.²³,Snowball Mary¹²³,Homan Chriss²³,Negus Susan¹²³,Roik Elena²³,Spradling Philip R.²³,Bruden Dana¹²³

Affiliation:

1. Liver Disease and Hepatitis Program Alaska Native Tribal Health Consortium Anchorage AK USA

2. Division of Preparedness and Emerging Infections National Center for Emerging and Zoonotic Infectious Diseases Centers for Disease Control and Prevention Arctic Investigations Program Anchorage AK USA

3. Division of Viral Hepatitis National Center for HIV Viral Hepatitis STD and TB Prevention Centers for Disease Control and Prevention Atlanta GA USA

Funder

Centers for Disease Control and Prevention

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.32065

Reference24 articles.

1. Screening for hepatocellular carcinoma: The rationale for the American Association for the Study of Liver Diseases recommendations

2. Management of hepatocellular carcinoma: An update

3. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance